Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01742962
Other study ID # 2007-58-0015 / HEH.750.19-31
Secondary ID H-2-2012-FSP43
Status Completed
Phase N/A
First received December 4, 2012
Last updated July 1, 2014
Start date December 2012
Est. completion date September 2013

Study information

Verified date July 2014
Source Copenhagen University Hospital at Herlev
Contact n/a
Is FDA regulated No
Health authority Denmark: Danish Dataprotection AgencyDenmark: The Regional Committee on Biomedical Research Ethics
Study type Observational

Clinical Trial Summary

The purpose of this exploratory data collection is to strengthen our knowledge of some of the rarer distresses following surgical removal of the prostate. In general these are:

- Side effects related to sexuality, including:

- Altered perception of orgasm,

- Orgasm associated pain,

- Penile shortening and deformity.

- Side effects related to urinary incontinence.

- Urinary tract infection after operation.

- Influence of distress on sexual quality of life.

- Influence of distress on the patient´s sex drive.

In addition information on a range of demographics and information on the patient´s erectile function will be collected.


Description:

Approximately 1 out of 6 men will, at some point of their life become diagnosed with prostate cancer. Treatment options included medication therapy, radiation therapy, and surgery. This data collection aims to gather information on some of the lesser known distresses experienced by patients following surgical removal of the prostate gland.

Erectile dysfunction and urinary incontinence remain common, but thoroughly investigated side effects. Thus they will not be of primary interest here, but considered factors for correlation. During the last couple of years, a series of lesser known side effects have come to investigators attention. These include altered perception of orgasm, orgasm related pain, sexual-related urinary incontinence, and shortening -and impairing deviations of the penis. Few studies have investigated these side effects, and clear knowledge of why, and how often these problems arise, remain scarce. This study will contribute to that knowledge.

In addition, the questionnaire will include a series of exploratory questions, concerning lower urinary tract infections, treatment satisfaction, alcohol and urinary incontinence, reasons for abandoning treatment for erectile dysfunction, and an assessment of libido prior to and after radical prostatectomy.

The data collection will include approximately 400 patients from the department of urology at the University Hospital in Herlev, Copenhagen, Denmark. A questionnaire will be sent to patients together with a stamped addressed envelope in order to optimize the response rate. Results will be kept in a separate database from personal information.


Recruitment information / eligibility

Status Completed
Enrollment 396
Est. completion date September 2013
Est. primary completion date July 2013
Accepts healthy volunteers No
Gender Male
Age group N/A and older
Eligibility Inclusion Criteria:

- All patient who have undergone radical prostatectomy at the department of urology, Copenhagen University Hospital, Herlev, between 3 months and 3 years before initiation of the study.

Exclusion Criteria:

- Incontinence associated with sexual activity Prior to surgery

- Peyronies disease Prior to surgery

- Orgasm related pain Prior to surgery

- Anorgasmia Prior to surgery

Study Design

Observational Model: Cohort, Time Perspective: Cross-Sectional


Related Conditions & MeSH terms


Intervention

Procedure:
Radical prostatectomy for prostate cancer
Prior treatment with open or robot assisted laparoscopic prostatectomy.

Locations

Country Name City State
Denmark Copenhagen University Hospital in Herlev, Denmark Herlev

Sponsors (1)

Lead Sponsor Collaborator
Copenhagen University Hospital at Herlev

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Other Incidence of lower urinary tract infections following radical prostatectomy We want to know how large a percentage of patients treated with radical prostatectomy are experiencing a lower urinary tract infection post surgery. A momentary exploratory analysis of the problem in the study population, who are between 3 months and 3 years post radical prostatectomy. No
Other Incidence of alcohol related incontinence in patients undergone radical prostatectomy Does alcohol exacerbate incontinence symptoms? A momentary exploratory analysis of the problem in the study population, who are between 3 months and 3 years post radical prostatectomy. No
Other Impact of radical prostatectomy on the patients libido. Does radical prostatectomy influence patients libido? A momentary exploratory analysis of the problem in the study population, who are between 3 months and 3 years post radical prostatectomy. No
Other Patterns of use and discontinuation of use of aids for erectile dysfunction. A series of questions will investigate the patients use of aids for erectile dysfunction and reasons for discontinuation. A momentary exploratory analysis of the problem in the study population, who are between 3 months and 3 years post radical prostatectomy. No
Other Patient satisfaction with treatment. Assessed by a global satisfaction scale, and an evaluation of fulfillment of expectations prior to treatment. A momentary exploratory analysis of the problem in the study population, who are between 3 months and 3 years post radical prostatectomy. No
Other How do the patients gather knowledge of their disease? From which sources do the patients get their knowledge of prostate cancer. A momentary exploratory analysis of the problem in the study population, who are between 3 months and 3 years post radical prostatectomy. No
Primary Incidence of Urinary incontinence in relation to sexual activity measured as percentage of the population. The percentage of the study population experiencing urinary incontinence when engaging in sexual activity. A momentary exploratory analysis of the problem in the study population, who are between 3 months and 3 years post radical prostatectomy. No
Primary Incidence of altered perception of orgasm measured as percentage of the population. The percentage of the study population experiencing altered perception of orgasm. A momentary exploratory analysis of the problem in the study population, who are between 3 months and 3 years post radical prostatectomy. No
Primary Incidence of orgasm related pain measured as percentage of the population. The percentage of the study population experiencing orgasm related pain. A momentary exploratory analysis of the problem in the study population, who are between 3 months and 3 years post radical prostatectomy. No
Primary Incidence of impairing deviations or loss of length of the penis measured as percentage of the population. The percentage of the study population experiencing impairing deviations or loss of length of the penis. A momentary exploratory analysis of the problem in the study population, who are between 3 months and 3 years post radical prostatectomy. No
See also
  Status Clinical Trial Phase
Recruiting NCT05613023 - A Trial of 5 Fraction Prostate SBRT Versus 5 Fraction Prostate and Pelvic Nodal SBRT Phase 3
Recruiting NCT05540392 - An Acupuncture Study for Prostate Cancer Survivors With Urinary Issues Phase 1/Phase 2
Recruiting NCT05156424 - A Comparison of Aerobic and Resistance Exercise to Counteract Treatment Side Effects in Men With Prostate Cancer Phase 1/Phase 2
Completed NCT03177759 - Living With Prostate Cancer (LPC)
Completed NCT01331083 - A Phase II Study of PX-866 in Patients With Recurrent or Metastatic Castration Resistant Prostate Cancer Phase 2
Recruiting NCT05540782 - A Study of Cognitive Health in Survivors of Prostate Cancer
Active, not recruiting NCT04742361 - Efficacy of [18F]PSMA-1007 PET/CT in Patients With Biochemial Recurrent Prostate Cancer Phase 3
Completed NCT04400656 - PROState Pathway Embedded Comparative Trial
Completed NCT02282644 - Individual Phenotype Analysis in Patients With Castration-Resistant Prostate Cancer With CellSearch® and Flow Cytometry N/A
Recruiting NCT06037954 - A Study of Mental Health Care in People With Cancer N/A
Recruiting NCT06305832 - Salvage Radiotherapy Combined With Androgen Deprivation Therapy (ADT) With or Without Rezvilutamide in the Treatment of Biochemical Recurrence After Radical Prostatectomy for Prostate Cancer Phase 2
Recruiting NCT05761093 - Patient and Physician Benefit/ Risk Preferences for Treatment of mPC in Hong Kong: a Discrete Choice Experiment
Completed NCT04838626 - Study of Diagnostic Performance of [18F]CTT1057 for PSMA-positive Tumors Detection Phase 2/Phase 3
Recruiting NCT03101176 - Multiparametric Ultrasound Imaging in Prostate Cancer N/A
Completed NCT03290417 - Correlative Analysis of the Genomics of Vitamin D and Omega-3 Fatty Acid Intake in Prostate Cancer N/A
Completed NCT00341939 - Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
Completed NCT01497925 - Ph 1 Trial of ADI-PEG 20 Plus Docetaxel in Solid Tumors With Emphasis on Prostate Cancer and Non-Small Cell Lung Cancer Phase 1
Recruiting NCT03679819 - Single-center Trial for the Validation of High-resolution Transrectal Ultrasound (Exact Imaging Scanner ExactVu) for the Detection of Prostate Cancer
Completed NCT03554317 - COMbination of Bipolar Androgen Therapy and Nivolumab Phase 2
Completed NCT03271502 - Effect of Anesthesia on Optic Nerve Sheath Diameter in Patients Undergoing Robot-assisted Laparoscopic Prostatectomy N/A